摘要
对急慢性肝炎、原发性肝癌、胃癌、结直肠癌患者血清用ＥＬＩＳＡ法检测ＴＡＯ－Ｇ。结果：ＴＡＯ－Ｇ对急慢性肝炎的检测结果与正常人无显著性差异，Ｐ＞０．０５；恶性肿瘤的检测结果与正常人比较差异非常显著，Ｐ＜０．０１；对原发性肝癌、胃癌、结直肠癌的阳性率分别是６８．４％、７１．０％、６２．５％，胃癌的阳性诊断率较高。ＴＡＯ－Ｇ与ＡＦＰ、ＣＥＡ、ＣＡ－５０标志物联合应用，综合阳性率均较单项检测阳性率明显提高，统计处理联合检测两者间相关显著（Ｐ＜０．０１）。提示：ＴＡＯ－Ｇ的检测对消化系统肿瘤的早期诊断、鉴别诊断、避免单项检测出现的漏诊有重要的临床意义。
The serum TAO G was assaied with ELISA in patients with acute and chronic hepatitis,stomach cancer,primary hepatocarcinoma and colon or rectum cancer.Result:The value of TAO G from the patients with acute and chronic hepatitis was not much higher than normal value( P >0.05).The value of TAO G from the patients with primary hepatocarcinoma,stomach cancer,colon and rectum cancer was much higher than normal value ( P <0.01).The positive reaction rate of TAO G ELISA was 68.4%,71.0% and 62.5% respectively.The combined positive reaction rate of tumor markers was much higher than the positive reaction rate with single measurement.The statistic analysis showed that there was a significant correlation between the positive reaction rate of TAO G and other tumor marker assays( P <0.01).Prompt:TAO G assay and combined assay with other tumor markers may be useful in the diagnosis of malignant tumors.
出处
《免疫学杂志》
CAS
CSCD
北大核心
1997年第4期252-253,共2页
Immunological Journal
